Table 1.
Characteristic of GC patients
| Variable | N (%) |
|---|---|
| Sex | |
| Female | 523 (26.3) |
| Male | 1,467 (73.7) |
| Age (year) | |
| ≤62 | 1,232 (61.9) |
| >62 | 758 (38.1) |
| Tumor depth | |
| T1 | 124 (6.2) |
| T2 | 187 (9.4) |
| T3 | 512 (25.7) |
| T4 | 1,167 (58.7) |
| Lymph nodes | |
| N0 | 460 (23.1) |
| N1 | 343 (17.2) |
| N2 | 447 (22.5) |
| N3 | 740 (37.2) |
| Metastasis | |
| M0 | 1,781 (89.5) |
| M1 | 209 (10.5) |
| AJCC stage | |
| I | 162 (8.1) |
| II | 476 (23.9) |
| III | 1,143 (57.5) |
| IV | 209 (10.5) |
| Radicality | |
| R0 | 1,468 (73.8) |
| R1 or R2 | 522 (26.2) |
| Tumor size (cm) | |
| ≤6 | 1,290 (64.8) |
| >6 | 700 (35.2) |
| Location | |
| Upper | 273 (13.7) |
| Middle | 371 (18.6) |
| Low | 1,160 (58.3) |
| Whole | 186 (9.4) |
| MLNRa | |
| ≤31.5% | 1,155 (58.0) |
| >31.5% | 835 (42.0) |
| Differentiationb | |
| Differentiated | 322 (16.2) |
| Undifferentiated | 1,668 (83.8) |
| Ascites | |
| No | 1,912 (96.1) |
| Yes | 78 (3.9) |
| CA19–9 (U/mL) | |
| ≤37 | 1,556 (78.2) |
| >37 | 434 (21.8) |
| CEA (ng/mL) | |
| ≤5 | 1,527 (76.7) |
| >5 | 463 (23.3) |
| Hb (g/L) | |
| ≤130 | 1,014 (51.0) |
| >130 | 976 (49.0) |
| Tobacco | |
| Yes | 985 (49.5) |
| No | 1,005 (50.5) |
| dNLR | |
| ≤1.73 | 1,206 (60.6) |
| >1.73 | 784 (39.4) |
| MLR | |
| ≤0.22 | 917 (46.1) |
| >0.22 | 1,073 (53.9) |
| NLR | |
| ≤2.10 | 1,018 (51.2) |
| >2.10 | 972 (48.8) |
| PLR | |
| ≤139.12 | 908 (45.6) |
| >139.12 | 1,082 (54.4) |
| PNI | |
| ≤51.07 | 960 (48.2) |
| >51.07 | 1,030 (51.8) |
Notes:
a
The average point of MLNR was 31.5%.
b
Grades1 and 2 were differentiated, and grades 3 and 4 were undifferentiated.
Abbreviations: AJCC, American Joint Committee on Cancer; CEA, carcinoembryonic antigen; CA19-9, carbohydrate antigen 19-9; dNLR, derived neutrophil to lymphocyte ratio; GC, gastric cancer; Hb, hemoglobin; MLNR, Metastatic lymph nodes ratio; MLR, monocyte to lymphocyte ratio; NLR, neutrophil to lymphocyte ratio; PLR, platelet to lymphocyte ratio; PNI, prognostic nutritional index.